Wolfram Schafer

Marburg An Der Lahn, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Hepatitis E virus: Efficacy of pasteurization of plasma-derived VWF/FVIII concentrate determined by pig bioassay.

Hepatitis E virus: Efficacy of pasteurization of plasma-derived VWF/FVIII concentrate determined by pig bioassay.

Journal: Transfusion

Published: October 02, 2020

Effective coronavirus reduction by various production steps during the manufacture of plasma-derived medicinal products.

Effective coronavirus reduction by various production steps during the manufacture of plasma-derived medicinal products.

Journal: Transfusion

Published: April 06, 2020

Characterization of a quasi-enveloped, fast replicating hepevirus from fish and its use as hepatitis E virus surrogate.

Characterization of a quasi-enveloped, fast replicating hepevirus from fish and its use as hepatitis E virus surrogate.

Journal: Journal of virological methods

Published: August 23, 2018

High sensitivity of domestic pigs to intravenous infection with HEV.

High sensitivity of domestic pigs to intravenous infection with HEV.

Journal: BMC veterinary research

Published: August 07, 2018

Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors.

Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors.

Journal: Transfusion

Published: March 16, 2017

Effective inactivation of a wide range of viruses by pasteurization.

Effective inactivation of a wide range of viruses by pasteurization.

Journal: Transfusion

Published: February 10, 2017

Verification of effective Zika virus reduction by production steps used in the manufacture of plasma-derived medicinal products.

Verification of effective Zika virus reduction by production steps used in the manufacture of plasma-derived medicinal products.

Journal: Transfusion

Published: November 29, 2016

Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration.

Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration.

Journal: Transfusion

Published: August 05, 2016

Pathogen safety and characterisation of a highly purified human alpha1-proteinase inhibitor preparation.

Pathogen safety and characterisation of a highly purified human alpha1-proteinase inhibitor preparation.

Journal: Biologicals : journal of the International Association of Biological Standardization

Published: June 10, 2016

Pathogen safety of human C1 esterase inhibitor concentrate.

Pathogen safety of human C1 esterase inhibitor concentrate.

Journal: Transfusion

Published: March 15, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026